Erratum: Corrigendum to acute wake-promoting actions of JNJ-5207852, a novel, diamine-based H3 antagonist (British Journal of Pharmacology (2004) 143 (649-661) doi:10.1038/sj.bjp.0705964);Acute wake-promoting actions of JNJ-5207852, a novel, diamine-based H 3 antagonist

British Journal of Pharmacology

Volumn 143, Issue 5, 2004, Pages 649-661

  Barbier, A J ^a   Berridge, C ^b   Dugovic, C ^c   Laposky, A D ^c   Wilson, S J ^a   Boggs, J ^a   Aluisio, L ^a   Lord, B ^a   Mazur, C ^a   Pudiak, C M ^a   Langlois, X ^d   Xiao, W ^a   Apodaca, R ^a   Carruthers, N I ^a   Lovenberg, T W ^a  

^a JOHNSON AND JOHNSON PHARMACEUTICAL RESEARCH AND DEVELOPMENT   (United States)

^b UNIVERSITY OF WISCONSIN MADISON   (United States)

^c NORTHWESTERN UNIVERSITY   (United States)

^d JANSSEN RESEARCH AND DEVELOPMENT   (Belgium)

Author keywords

Arousal; Food intake; REM sleep; Sleep

Indexed keywords

1 [4 (3 PIPERIDIN 1 YLPROPOXY)BENZYL]PIPERIDINE; ALPHA METHYLHISTAMINE; HISTAMINE H3 RECEPTOR ANTAGONIST; ION CHANNEL; JNJ 5207852; PIPERIDINE DERIVATIVE; TRITIUM; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL TISSUE; AROUSAL; ARTICLE; AUTORADIOGRAPHY; BRAIN CORTEX; BRAIN SLICE; BRAIN TISSUE; CONTROLLED STUDY; CORPUS STRIATUM; DELTA RHYTHM; DRUG ABSORPTION; DRUG BRAIN LEVEL; DRUG EFFECT; DRUG RESPONSE; DRUG STRUCTURE; FEMALE; FOOD INTAKE; HUMAN; HYPOTHALAMUS; KNOCKOUT MOUSE; MALE; NONHUMAN; PRIORITY JOURNAL; RAT; RECEPTOR AFFINITY; REM SLEEP; SLOW WAVE SLEEP; WAKEFULNESS;

EID: 8744233669     PISSN: 00071188     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.bjp.0706119     Document Type: Erratum

References (48)

1. 3 receptor in rat cerebral cortex. Br. J. Pharmacol., 118, 2045-2052.
2. 3 receptor ligands with combined inhibitory histamine N-methyltransferase activity. Bioorg. Med. Chem. Lett., 13, 1767-1770.
3. 3 receptor ligands: 4-(aminoalkoxy)-benzylamines. J. Med. Chem., 46, 3938-3944.
4. 3) of histamine receptor. Nature (Lond.), 302, 832-837.
5. 3 receptors. Neuroscience, 23, 149-157.
6. 3 receptor is involved in cholecystokinin inhibition of food intake in rats. Life Sci., 69, 469-478.
7. BERRIDGE, C.W. & FOOTE, S.L (1996). Enhancement of behavioral and electroencephalographic indices of waking following stimulation of noradrenergic beta-receptors within the medial septal region of the basal forebrain. J. Neurosci., 16, 6999-7009.
8. 1A/1B double-knockout mice. J. Pharmacol. Exp. Ther., 302, 240-248.
9. BROWN, R.E., STEVENS, D.R. & HAAS, H.L. (2001). The physiology of brain histamine. Progr. Neurobiol., 63, 637-672.
10. 50) of an enzymatic reaction. Biochem. Pharmacol., 22, 3099-3108.
11. CHILDERS, S.R. & SNYDER, S.H. (1980). Differential regulation by guanine nucleotides or opiate agonist and antagonist interactions. J. Neurochem., 34, 583-593.
12. EDGAR, D.M. & SEIDEL, W.F. (1997). Modafinil induces wakefulness without intensifying motor activity or subsequent rebound hypersomnolence in the rat. J. Pharmacol. Exp. Ther., 283, 757-769.
13. ESBENSHADE, T., KRUEGER, K., DENNY, L.I., MILLER, T., KANG, C.H., WITTE, D., YAO, B., BLACK, L., BENNANI, Y., FOX, G.B., PAN, J.B., DECKER, M.W. & HANCOCK, A. (2001). Complex pharmacological effects of GT-2331. Soc. Neurosci., abstract 378.1.
14. 3 receptor ligands. Part I. Bioorg. Med. Chem. Lett., 12, 2031-2034.
15. 3 receptor ligands GT-2331 and ciproxifan in a repeated acquisition avoidance response in the spontaneously hypertensive rat pup. Behav. Brain Res., 131, 151-161.
16. 3 receptor antagonists/inverse agonists as anti-obesity agents. Curr. Opin. Invest. Drugs., 4, 1190-1197.
17. 3 receptor antagonist. Eur. J. Pharmacol., 487, 183-197.
18. 3 receptor antagonists exemplified by A-331440. Abstract 3, Abstract Book of the American Chemical Society. 225th National Meeting, New Orleans, LA, March 25-27, 2003.
19. 4 receptor mediates chemotaxis and calcium mobilization of mast cells. J. Pharmacol. Exp. Ther., 305, 1212-1221.
20. 3 receptor antagonist, powerfully suppresses peptide YY-induced food intake in rats. Biol. Psych., 45, 475-481.
21. LANGLOIS, X, TE RIELE, P., WINTMOLDERS, C., LEYSEN, J.E. & JURZAK, M. (2001). Use of the β-Imager for rapid ex-vivo autoradiography exemplified with CNS penetrating neurokinin 3 antagonists. J. Pharmacol. Exp. Ther., 299, 712-717.
22. 3 receptor antagonist. J. Pharmacol. Exp. Ther., 287, 658-666.
23. LIN, J.S., HOU, Y., SAKAI, K. & JOUVET, M. (1996). Histaminergic descending inputs to the mesopontine tegmentum and their role in the control of cortical activation and wakefulness in the cat. J. Neurosci., 16, 1523-1537.
24. LIN, J.S., SAKAI, K. & JOUVET, M. (1994). Hypothalamo-preoptic histaminergic projections in sleep-wake control in the cat. Eur. J. Neurosci., 6, 618-625.
25. 3-receptor ligands in the cat. Brain Res., 523, 325-330.
26. 3 receptor antagonists. J. Med. Chem., 43, 2362-2370.
27. 3 receptor reveals distinct species pharmacological profiles. J. Pharmacol. Exp. Ther., 293, 771-778.
28. 3 receptor agonist inhibits central neurogenic vascular inflammation and produces sedation in the guinea pig. J. Pharmacol. Exp. Ther., 287, 43-50.
29. MARTIN, N.A., RUCKLE, M.B., VANHOOF, S.L. & PRATHER, P.L. (2002). Agonist, antagonist and inverse agonist characteristics of TIPP (H-Tyr-Tic-Phe-Phe-OH), a selective δ-opioid receptor ligand. J. Pharmacol. Exp. Ther., 301, 661-671.
30. MOCHIZUKI, T., YAMATODANI, A., OKAKURA, K., HORII, A., INAGAKI, N. & WADA, H. (1992). Orcadian rhythm of histamine release from the hypothalamus of freely moving rats. Physiol. Behav., 51, 391-394.
31. MONTI, J.M., D'ANGELO, L., JANTOS, H. & PRAZOS, S. (1988). Effects of α-fluoromethylhistidine on sleep and wakefulness in the rat. J. Neural Transm., 72, 141-145.
32. 3 receptor on sleep and wakefulness. Eur. J. Pharmacol., 205, 283-287.
33. 3 antagonist carboperamide (MR 16155) administration in rats. Neuropsychopharmacology, 15, 31-35.
34. 2-histamine receptor agonists and antagonists on sleep and wakefulness in the rat. J. Neural Transm., 66, 1-11.
35. 3 receptors regulates histamine neurons in the brain. Nature, 408, 860-864.
36. PARMENTIER, R., OHTSU, H., DJEBBARA-HANNAS, Z., VALATX, J.L., WATANABE, T. & LIN, J.S. (2002). Anatomical, physiological, and pharmacological characteristics of histidine decarboxylase knock-out mice: evidence for the role of brain histamine in behavioral and sleep-wake control. J. Neurosci., 22, 7695-7711.
37. 3 receptor and its gene transcripts in rat brain. Neuroscience, 114, 173-193.
38. 3 receptor antagonists. Bioorg. Med. Chem. Lett., 13, 1767-1770.
39. 3-receptor-induced attenuation of norephinephrine exocytosis from cardiac sympathetic nerve endings. Proc. Natl. Acad. Sci. U.S.A., 99, 501-506.
40. 3-receptor antagonists. Drugs Future, 21, 507-520.
41. 3 receptors results in changes in brain histamine tone leading to an obese phenotype. J. Clin. Invest., 110, 1791-1799.
42. 3 receptor antagonist, GT-2331, on rat sleep-wakefulness and canine cataplexy. Soc. Neurosci. Abs., 26, 460.3.
43. 3 receptors. Mol. Pharmacol., 62, 389-397.
44. 3-receptor ligands: an electrophysiological study in freely moving cats. Behav. Brain Res., 144, 227-241.
45. 1 blocking activities. Farmako, 54, 684-694.
46. 3 antagonists. J. Pharmacol. Exp. Ther., 299, 908-914.
47. 3 receptor as appetite suppressants. Abstract 2, Abstract Book of the American Chemical Society. 225th National Meeting, New Orleans, LA, March 25-27, 2003.
48. YOSHIMATSU, H., ITATEYAMA, E., KONDOU, S., TAJIMA, D., HIMENO, K., HIDAKA, S., KUROKAWA, M. & SAKATA, T. (1999). Hypothalamic neuronal histamine as a target of leptin in feeding behavior. Diabetes, 48, 2286-2291.